Abstract:Objective To investigate the killing activity of H22-DC-TIL[tumor infiltrating lymphocytes(TIL) stimulated by dendritic cells(DC) that were sensitized by H22 cell antigen] on carcinoma cells in vitro and to explore the influence of immune and inhibition of the progression of tumor after adoptive immunotherapy with H22-DC-TIL on mice bearing tumor.Methods DC were isolated from mouse bone marrow and sensitized by granulocyte/ macrophage colony stimulating factor(GM-CSF),interleukin-4(IL-4) and tumor antigen.Then TIL were stimulated by DC and their killing activity on H22,Hepal-6 and B16 cells were observed in vitro.The activities of splenocyte NK,LAK,CTL,serum TNF,inhibition of the progression of tumor and pathologic change of tumor of mice bearing tumor were assayed respectively after treated with H22-DC-TIL,and compared with control groups.Results ① H22-DC-TIL had very high killing activity on H22 cells [killing rate:(71.31±3.11)%],it was higher killing activity than those on Hepal-6 and B16 cells [killing rates:(50.11±3.03)%,(30.31±2.89)%,respectively],and it also was much higher killing activity than those of TIL not stimulated by DC and splenocytes stimulated by DC as well as splenocytes not stimulated by DC on H22 cells[killing rates:(49.80±3.21)%,(48.76±3.60)%,(19.23±2.71)%,respectively],on Hepal-6 cells [killing rates:(39.40±(3.21))%,(38.62±2.87)%,(18.73±2.40)%,respectively] and on B16 cells [killing rates:(26.38±2.51)%,(25.82±2.70)%,((18.34)±3.01)%,respectively],B16-DC-TIL [TIL stimulated by DC that were sensitized by B16 cell antigen,and the TIL came from H22 tumor] had relative lower killing activity on B16 cells.② The activities of splenocyte NK,LAK,CTL and serum TNF of mice bearing tumor can be induced to enhance obviously by H22-DC-TIL,they reached the level of normal group,and had significant difference comparing with TIL not stimulated by DC group,splenocytes stimulated by DC group and splenocytes not stimulated by DC group as well as normal saline group(P0.01).The level of lymphocytes infiltrating in tumor of the group higher than those of the control groups,and tumor progression in mice bearing tumor also was significantly inhibited(P0.01).Conclusion ①H22-DC-TIL has very high specific killing activity on H22 cells.② H22-DC-TIL has very strong specific anti-mouse hepatocellular carcinoma effect.

H22 tumor cell lysate plus adjuvants can effectively induce anti-tumor immunity

Antitumor Effect of Immunizations with Fusions of Dendritic and Hepatocellular Carcinoma Cells in Mice

Experimental Study of Specific Immunotherapy Induced by H22 Autologous Tumor As Whole Tumor Cell Vaccine.

Anti-Tumor Effects of B16F10 Tumor Cell Lysate Vaccine in Mouse Melanoma

Improved Efficacy of Therapeutic Vaccination with Dendritic Cells Pulsed with Tumor Cell Lysate Against Hepatocellular Carcinoma by Introduction of 2 Tandem Repeats of Microbial HSP70 Peptide Epitope 407–426 and OK-432

Effect of Tumor-Associated Antigen Peptide Extract from H-22 Hepatocarcinoma on Immune Function and Tumor-Inhibition in Mice

Protective Antitumor Immunity Induced by Tumor Cell Lysates Conjugated with Diphtheria Toxin and Adjuvant Epitope in Mouse Breast Tumor Models

Antitumor Mechanism of the Tumor-Infiltrating Lymphocyte Stimulated by Mice Bone Marrow DCs Pulsed with Mice Hepatoma H22 Full-Cell Antigen

Enhanced Antitumor Efficacy by Combination Treatment with a Human Umbilical Vein Endothelial Cell Vaccine and a Tumor Cell Lysate-Based Vaccine

Study on immune function of mice bearing tumor affected by TIL stimulated by DC

Antitumor therapeutic effect induced by intestine- carcinoma cells vaccine expressing membrane- bound heat shock protein 70

Generation of Antitumor Vaccines for H22 Tumor on Mouse Using Photodynamic Therapy

Study of Anti-mouse Hepatocellular Carcinoma Activities of TIL Affected by DC

Antitumor Effect of Immunization with Fusion of Dendritic Cells and Hepatocellular Carcinoma Cells in Mice.

Influences of low dose radiation on inhibitory effects of tumor-associated antigen peptide extract of H-22 hepatocarcinoma in mice

[Immunization with Dendritic Cells Infected with Mtert Adenovirus Vector Effectively Elicits Immunity Against Mouse H22 Hepatoma in Vivo].

Anti-Tumor Effects of Tumor Cell Lysate Vaccine and Its Modified Dendritic Cells on A20 Murine Lymphoma

Anti-metastatic effects of DNA vaccine encoding single-chain trimer composed of MHC I and vascular endothelial growth factor receptor 2 peptide.

Active Specific Immunotherapy of Mice Bearing Liver Cancer Using Novel Whole Cell Tumor Vaccine

[Application of Fusion Gene Mgm-Csf/hil-2 to Specific Immunotherapy Induced by Hepatic Tumor Cell Vaccine].

Suppression of Established Hepatocarcinoma in Adjuvant Only Immunotherapy: Alum Triggers Anti-Tumor CD8+ T Cell Response.